Overview Dividends

(OHI) Omega Healthcare Investors - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US6819361006

Skilled Nursing, Assisted Living, Care Homes, Healthcare REIT

Health Care REITs
Market Cap in USD: 13,526m

IPO / Inception: 1992-08-07
Return 12m vs S&P 500: 6.94%

EPS (Earnings per Share)

EPS CAGR: 46.67%
EPS Trend: 39.0%

Last SUE: 1.59
Qual. Beats: 2

Revenue

Rev. CAGR: 6.05%
Rev. Trend: 52.6%

Last SUE: 0.80
Qual. Beats: 0

Dividends

Dividend Yield	6.00%
Yield on Cost 5y	11.42%
Yield CAGR 5y	0.00%
Payout Consistency	87.4%
Payout Ratio	141.2%

Risk via 5d forecast
Volatility	20.0%
Value at Risk 5%th	32.1%
Relative Tail Risk	-2.38%

Reward TTM
Sharpe Ratio	1.16
Alpha	22.19
CAGR/Max DD	1.73

Character TTM
Hurst Exponent	0.457
Beta	0.148
Beta Downside	0.099

Drawdowns 3y
Max DD	15.47%
Mean DD	4.77%
Median DD	4.46%

Description: OHI Omega Healthcare Investors January 03, 2026

Omega Healthcare Investors (NYSE: OHI) is a publicly-traded REIT that finances and owns long-term care properties-primarily skilled-nursing and assisted-living facilities-in the United States and the United Kingdom. As of the most recent quarter (Sept 30 2025) the portfolio comprises 1,024 operating sites across 42 U.S. states, D.C., and the U.K./Jersey (including 290 U.K. care homes), managed by 88 distinct operators, plus an additional 19 facilities held through unconsolidated entities. The REIT’s stated objective is to acquire “quality” healthcare assets with strong operators to maximize a favorable risk-adjusted return for shareholders.

Key quantitative signals (as of Q3 2025) include a weighted-average lease-expiry horizon of 7.2 years, an occupancy-adjusted net operating income (NOI) margin of roughly 38 %, and a dividend yield near 6.5 %-both above the median for Health Care REITs. The sector’s fundamentals are driven by demographic aging (U.S. Medicare-eligible population projected to rise 10 % by 2030) and constrained supply of skilled-nursing beds, which historically supports rent-growth rates of 2-3 % annually. However, operator credit risk and regulatory reimbursement changes remain material uncertainties that could compress yields.

For a deeper, data-rich view of OHI’s valuation dynamics, you may find ValueRay’s interactive dashboards useful.

Piotroski VR‑10 (Strict, 0-10) 4.5

Net Income (538.7m TTM) > 0 and > 6% of Revenue (6% = 69.0m TTM)

FCFTA 0.08 (>2.0%) and ΔFCFTA 1.13pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 213.1% (prev 202.0%; Δ 11.07pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.08 (>3.0%) and CFO 876.2m > Net Income 538.7m (YES >=105%, WARN >=100%)

Net Debt (4.26b) to EBITDA (1.11b) ratio: 3.83 <= 3.0 (WARN <= 3.5)

Current Ratio 7.86 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (308.2m) change vs 12m ago 11.84% (target <= -2.0% for YES)

Gross Margin 98.83% (prev 95.33%; Δ 3.50pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 11.41% (prev 10.57%; Δ 0.84pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 3.62 (EBITDA TTM 1.11b / Interest Expense TTM 218.5m) >= 6 (WARN >= 3)

Altman Z'' 0.26

(A) 0.23 = (Total Current Assets 2.81b - Total Current Liabilities 357.4m) / Total Assets 10.60b

(B) -0.34 = Retained Earnings (Balance) -3.59b / Total Assets 10.60b

(D) -0.65 = Book Value of Equity -3.48b / Total Liabilities 5.35b

Total Rating: 0.26 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 69.37

1. Piotroski 4.50pt

2. FCF Yield 4.73%

3. FCF Margin 73.11%

4. Debt/Equity 0.99

5. Debt/Ebitda 3.83

6. ROIC - WACC (= 2.90)%

7. RoE 11.16%

8. Rev. Trend 52.56%

9. EPS Trend 38.99%

What is the price of OHI shares?

As of January 09, 2026, the stock is trading at USD 44.68 with a total of 1,832,577 shares traded.
Over the past week, the price has changed by +0.34%, over one month by -2.21%, over three months by +11.61% and over the past year by +26.55%.

Is OHI a buy, sell or hold?

Omega Healthcare Investors has received a consensus analysts rating of 3.69. Therefor, it is recommend to hold OHI.

Strong Buy: 4
Buy: 3
Hold: 9
Sell: 0
Strong Sell: 0

What are the forecasts/targets for the OHI price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	46.5	4%
Analysts Target Price	46.5	4%
ValueRay Target Price	57.4	28.4%

OHI Fundamental Data Overview January 05, 2026

Market Cap USD = 13.53b (13.53b USD * 1.0 USD.USD)
P/E Trailing = 24.7389
P/E Forward = 10.1317
P/S = 11.7593
P/B = 2.6131
P/EG = 1.13
Beta = 0.554
Revenue TTM = 1.15b USD
EBIT TTM = 790.3m USD
EBITDA TTM = 1.11b USD
Long Term Debt = 4.99b USD (from longTermDebt, last quarter)
Short Term Debt = 879.1m USD (from shortTermDebt, last fiscal year)
Debt = 4.99b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.26b USD (from netDebt column, last quarter)
Enterprise Value = 17.78b USD (13.53b + Debt 4.99b - CCE 737.2m)
Interest Coverage Ratio = 3.62 (Ebit TTM 790.3m / Interest Expense TTM 218.5m)
FCF Yield = 4.73% (FCF TTM 840.9m / Enterprise Value 17.78b)
FCF Margin = 73.11% (FCF TTM 840.9m / Revenue TTM 1.15b)
Net Margin = 46.83% (Net Income TTM 538.7m / Revenue TTM 1.15b)
Gross Margin = 98.83% ((Revenue TTM 1.15b - Cost of Revenue TTM 13.5m) / Revenue TTM)
Gross Margin QoQ = 98.88% (prev 98.85%)
Tobins Q-Ratio = 1.68 (Enterprise Value 17.78b / Total Assets 10.60b)
Interest Expense / Debt = 1.16% (Interest Expense 58.1m / Debt 4.99b)
Taxrate = 2.37% (4.48m / 189.4m)
NOPAT = 771.6m (EBIT 790.3m * (1 - 2.37%))
Current Ratio = 7.86 (Total Current Assets 2.81b / Total Current Liabilities 357.4m)
Debt / Equity = 0.99 (Debt 4.99b / totalStockholderEquity, last quarter 5.04b)
Debt / EBITDA = 3.83 (Net Debt 4.26b / EBITDA 1.11b)
Debt / FCF = 5.06 (Net Debt 4.26b / FCF TTM 840.9m)
Total Stockholder Equity = 4.83b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.08% (Net Income 538.7m / Total Assets 10.60b)
RoE = 11.16% (Net Income TTM 538.7m / Total Stockholder Equity 4.83b)
RoCE = 8.05% (EBIT 790.3m / Capital Employed (Equity 4.83b + L.T.Debt 4.99b))
RoIC = 8.00% (NOPAT 771.6m / Invested Capital 9.65b)
WACC = 5.10% (E(13.53b)/V(18.52b) * Re(6.56%) + D(4.99b)/V(18.52b) * Rd(1.16%) * (1-Tc(0.02)))
Discount Rate = 6.56% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 100.0 | Cagr: 9.60%
[DCF Debug] Terminal Value 79.04% ; FCFE base≈765.1m ; Y1≈806.5m ; Y5≈950.8m
Fair Price DCF = 56.37 (DCF Value 16.66b / Shares Outstanding 295.5m; 5y FCF grow 5.91% → 3.0% )
EPS Correlation: 38.99 | EPS CAGR: 46.67% | SUE: 1.59 | # QB: 2
Revenue Correlation: 52.56 | Revenue CAGR: 6.05% | SUE: 0.80 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.47 | Chg30d=+0.000 | Revisions Net=-1 | Analysts=1
EPS next Year (2026-12-31): EPS=1.94 | Chg30d=+0.030 | Revisions Net=-1 | Growth EPS=+11.1% | Growth Revenue=+4.8%

Additional Sources for OHI Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle